Works matching IS 02724391 AND DT 1994 AND VI 31 AND IP 1
1
- Drug Development Research, 1994, v. 31, n. 1, p. 1, doi. 10.1002/ddr.430310102
- Levin, Edward D.;
- Rosecrans, John A.
- Article
2
- Drug Development Research, 1994, v. 31, n. 1, p. 32, doi. 10.1002/ddr.430310106
- Levin, Edward D.;
- Eisner, Batya
- Article
3
- Drug Development Research, 1994, v. 31, n. 1, p. fmi, doi. 10.1002/ddr.430310101
- Article
4
- Drug Development Research, 1994, v. 31, n. 1, p. 80, doi. 10.1002/ddr.430310112
- Sahakian, Barbara J.;
- Coull, Jennifer T.
- Article
5
- Drug Development Research, 1994, v. 31, n. 1, p. 24, doi. 10.1002/ddr.430310105
- Widzowski, Daniel V.;
- Cregan, Edward;
- Bialobok, Paul
- Article
6
- Drug Development Research, 1994, v. 31, n. 1, p. 52, doi. 10.1002/ddr.430310109
- Decker, Michael W.;
- Buckley, Michael J.;
- Brioni, Jorge D.
- Article
7
- Drug Development Research, 1994, v. 31, n. 1, p. 71, doi. 10.1002/ddr.430310111
- Newhouse, Paul A.;
- Potter, Alexandra;
- Corwin, June;
- Lenox, Robert
- Article
8
- Drug Development Research, 1994, v. 31, n. 1, p. 18, doi. 10.1002/ddr.430310104
- Brucato, Frederic H.;
- Levin, Edward D.;
- Rose, Jed E.;
- Swartzwelder, H. Scott
- Article
9
- Drug Development Research, 1994, v. 31, n. 1, p. 45, doi. 10.1002/ddr.430310108
- Porter, Joseph H.;
- Heath, Gregory F.;
- Rosecrans, John A.
- Article
10
- Drug Development Research, 1994, v. 31, n. 1, p. 59, doi. 10.1002/ddr.430310110
- Bättig, Karl;
- Kos, Jiri;
- Hasenfratz, Markus
- Article
11
- Drug Development Research, 1994, v. 31, n. 1, p. 3, doi. 10.1002/ddr.430310103
- Gray, Jeffrey A.;
- Mitchell, Stephen N.;
- Joseph, Michael H.;
- Grigoryan, Grigory A.;
- Dawe, Sharon;
- Hodges, Helen
- Article
12
- Drug Development Research, 1994, v. 31, n. 1, p. 38, doi. 10.1002/ddr.430310107
- O'Neill, Alyssa B.;
- Brioni, Jorge D.
- Article